Sign in
4

Changes in Ownership

Evofem Biosciences, Inc. Filed Acc 0001618835-21-000108

Options or other derivatives

  • Director acquired 90,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Hall William Walmsley · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-05-12 Grant or award : show line 1 in the form Stock option (right to buy) +90,000 90,000 D
Loading xslF345X03/wf-form4_162093677602785.xml…